The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease

Respiration

Volumn 85, Issue 2, 2013, Pages 98-105

  Li, Jing ^a   Huang, Yun ^a   Fei, Guang He ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Arterial blood gas; Chronic obstructive pulmonary disease; Clusterin; Cognitive performance; Pulmonary function

Indexed keywords

CLUSTERIN;

AGED; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVALUATION STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT PARAMETERS;

EID: 84874108454     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000342970     Document Type: Article

References (35)

1. Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
2. van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75: 224-238.
3. Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G: Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010; 80: 112-119.
4. Jan Ankersmit H, Nickl S, Hoeltl E, Toepker M, Lambers C, Mitterbauer A, Kortuem B, Zimmermann M, Moser B, Bekos C, Steinlechner B, Hofbauer H, Klepetko W, Schenk P, Dome B: Increased serum levels of HSP27 as a marker for incipient chronic obstructive pulmonary disease in young smokers. Respiration 2012; 83: 391-399.
5. Dodd JW, Getov SV, Jones PW: Cognitive function in COPD. Eur Respir J 2010; 35: 913-922.
6. Lima OM, Oliveira-Souza R, Santos Oda R, Moraes PA, Sá LF, Nascimento OJ: Subclinical encephalopathy in chronic obstructive pulmonary disease. Arq Neuropsiquiatr 2007; 65: 1154-1157.
7. Antonelli Incalzi R, Marra C, Giordano A, Calcagni ML, Cappa A, Basso S, Pagliari G, Fuso L: Cognitive impairment in chronic obstructive pulmonary disease-a neuropsychological and spect study. J Neurol 2003; 250: 325-332.
8. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, Mahurin R, Richards T, Anzai Y, Yukawa M, Yeh S: Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis 2008; 3: 429-434.
9. Trougakos IP, Gonos ES: Chapter 9: oxidative stress in malignant progression: the role of Clusterin, a sensitive cellular biosensor of free radicals. Adv Cancer Res 2009; 104: 171-210.
10. Nuutinen T, Suuronen T, Kauppinen A, Salminen A: Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 2009; 61: 89-104.
11. Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, Güntert A, Kraut M, Ferrucci L, Davatzikos C, Lovestone S, Resnick SM: Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 2012; 59: 212-217.
12. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S: Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 2010; 67: 739-748.
13. Rodriguez-Roisin R, Anzueto A, Bourbean J, DeGuia TS, Hui D, Jenkin C, Martinez F, Mishima M, Montes de Oca M, Stockley R, van Weel C, Vestbo J: Global initiative for chronic obstructive lung disease. GOLD Executive Committee 2010. http://www. goldcopd.org/uploads/u s e r s/f i le s/GOLDReport-April112011.pdf.
14. Swan GE, Lessov-Schlaggar CN: The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 2007; 17: 259-273.
15. Isajevs S, Taivans I, Svirina D, Strazda G, Kopeika U: Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration 2011; 81: 362-371.
16. Alonso A, Mosley TH Jr, Gottesman RF, Catellier D, Sharrett AR, Coresh J: Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry 2009; 80: 1194-1201.
17. Bawden FC, Oliveira CA, Caramelli P: Impact of obstructive sleep apnea on cognitive performance. Arq Neuropsiquiatr 2011; 69: 585-589.
18. Paulo AC, Sampaio A, Santos NC, Costa PS, Cunha P, Zihl J, Cerqueira J, Palha JA, Sousa N: Patterns of cognitive performance in healthy ageing in Northern Portugal: a cross-sectional analysis. PLoS One 2011; 6:e24553.
19. Mueller K, Anwander A, Möller HE, Horstmann A, Lepsien J, Busse F, Mohammadi S, Schroeter ML, Stumvoll M, Villringer A, Pleger B: Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One 2011; 6:e18544.
20. Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carhonin P: Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest 1997; 112: 1506-1513.
21. Hung WW, Wisnivesky JP, Siu AL, Ross JS: Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 134-137.
22. Ozge C, Ozge A, Unal O: Cognitive and functional deterioration in patients with severe COPD. Behav Neurol 2006; 17: 121-130.
23. Thakur N, Blanc PD, Julian LJ, Yelin EH, Katz PP, Sidney S, Iribarren C, Eisner MD: COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 2010; 5: 263-269.
24. Chyou PH, White LR, Yano K, Sharp DS, Burchfiel CM, Chen R, Rodriguez BL, Curb JD: Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol 1996; 143: 750-756.
25. Sachdev PS, Anstey KJ, Parslow RA, Wen W, Maller J, Kumar R, Christensen H, Jorm AF: Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord 2006; 21: 300-308.
26. Etnier J, Johnston R, Dagenbach D, Pollard RJ, Rejeski WJ, Berry M: The relationships among pulmonary function, aerobic fitness, and cognitive functioning in older COPD patients. Chest 1999; 116: 853-960.
27. Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F; SaRA Investigators: Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 2003; 22: 444-449.
28. Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, van der Molen T, Riemersma RA, van Zomeren EH, Kerstjens HA: Cognitive performance in patients with COPD. Respir Med 2004; 98: 351-356.
29. Nel A: Atmosphere. Air pollution-related illness: effects of particles. Science 2005; 308: 804-806.
30. Maccioni RB, Rojo LE, Fernández JA, Kuljis RO: The role of neuroimmunomodulation in Alzheimer's disease. Ann NY Acad Sci 2009; 1153: 240-246.
31. Gibson GE, Pulsinelli W, Blass JP, Duffy TE: Brain dysfunction in mild to moderate hypoxia. Am J Med 1981; 70: 1247-1254.
32. Weuve J, Glymour MM, Hu H, Sparrow D, Spiro A 3rd, Vokonas PS, Litonjua AA: Forced expiratory volume in 1 second and cognitive aging in men. J Am Geriatr Soc 2011; 59: 1283-1292.
33. Ortapamuk H, Naldoken S: Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006; 20: 99-106.
34. Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM: Plasma clusterin and the risk of Alzheimer disease. JAMA 2011; 305: 1322-1326.
35. van Durme YM, Lahousse L, Verhamme KM, Stolk L, Eijgelsheim M, Loth DW, Uitterlinden AG, Breteler MM, Joos GF, Hofman A, Stricker BH, Brusselle GG: Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease. Respiration 2011; 82: 530-538.